Image pharmaphorum Editor Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data. Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others. Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency. Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important? Load more results
Patients Leveraging real-world data to meet payers’ needs Payers are becoming savvier in accepting real-world data.
Patients Time to take patient engagement to the next level Patient engagement in pharma is evolving, with some companies doing it better than others.
Patients Patients want to be heard. Is pharma listening? A common theme heard from the advocacy groups AXON works with is “Nothing for us without us,” says Natalie Turner, director at AXON, a global healthcare communications agency.
Patients Health literacy for the intellectually disabled: is pharma d... What is health literacy and why is it important?
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.